POET Technologies (POET) Stock Chart & Stock Price History → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free POET Stock Alerts $2.02 -0.07 (-3.35%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media POET Technologies Stock Price Performance5 Day Performance-1.46%1 Month Performance+69.75%3 Month Performance+54.20%6 Month Performance+57.81%Year-To-Date Performance+115.95%1 Year Performance-54.30% Receive POET Stock News and Ratings via Email Sign-up to receive the latest news and ratings for POET Technologies and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. POET Stock Chart for Wednesday, May, 8, 2024 POET Chart by TradingView POET Technologies Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$2.09$2.02-3.35%$2.13$1.97391,030 shs$97.44 million05/07/2024$2.12$2.09-1.42%$2.25$2.07613,422 shs$100.82 million05/06/2024$2.05$2.12+3.41%$2.33$2.10957,484 shs$102.27 million05/03/2024$2.37$2.05-13.50%$2.32$1.992.36 million shs$98.89 million05/02/2024$2.69$2.37-11.90%$2.86$2.331.04 million shs$114.33 million05/01/2024$2.74$2.69-1.82%$2.85$2.172.13 million shs$129.77 million Get the Latest News and Ratings for POET and Related StocksEnter your email address below to receive the latest news and analysts' ratings for POET Technologies and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$2.94$2.74-6.80%$3.41$2.513.68 million shs$132.18 million04/29/2024$2.50$2.94+17.60%$2.99$2.513.74 million shs$141.83 million04/26/2024$1.98$2.50+26.26%$2.60$2.093.27 million shs$120.60 million04/25/2024$2.28$1.98-13.16%$2.42$1.754.27 million shs$95.52 million04/24/2024$1.58$2.28+44.30%$2.34$1.636.19 million shs$109.99 million04/23/2024$1.25$1.58+26.40%$1.67$1.284.22 million shs$76.22 million04/22/2024$1.05$1.25+19.05%$1.38$1.203.90 million shs$60.30 million04/19/2024$1.00$1.04+3.73%$1.04$1.0041,588 shs$50.17 million04/18/2024$1.06$1.00-5.47%$1.07$1.0053,740 shs$51.16 million04/17/2024$1.11$1.06-4.45%$1.12$1.0626,124 shs$51.16 million04/16/2024$1.01$1.11+9.65%$1.20$1.0275,080 shs$53.55 million04/15/2024$1.09$1.01-7.13%$1.12$1.0069,730 shs$48.83 million04/12/2024$1.14$1.12-1.75%$1.17$1.0772,986 shs$54.03 million04/11/2024$1.12$1.14+1.79%$1.14$1.1056,222 shs$54.97 million04/10/2024$1.20$1.12-6.67%$1.25$1.11114,837 shs$54.01 million04/09/2024$1.19$1.20+0.84%$1.20$1.1533,493 shs$57.86 million04/08/2024$1.20$1.19-0.83%$1.25$1.1730,667 shs$57.38 million04/05/2024$1.30$1.20-7.69%$1.34$1.18103,802 shs$57.86 million04/04/2024$1.30$1.30$1.37$1.2623,459 shs$62.68 million04/03/2024$1.30$1.30$1.33$1.2932,293 shs$62.63 million04/02/2024$1.32$1.30-1.52%$1.35$1.2855,368 shs$62.63 million04/01/2024$1.37$1.32-3.65%$1.38$1.3054,916 shs$63.60 million03/29/2024$1.37$1.37$1.40$1.3529,765 shs$66.01 million03/28/2024$1.37$1.37$1.40$1.3529,648 shs$66.01 million03/27/2024$1.31$1.37+4.58%$1.47$1.3249,901 shs$66.01 million03/26/2024$1.34$1.31-2.24%$1.43$1.3181,045 shs$63.12 million03/25/2024$1.39$1.34-3.60%$1.43$1.2570,662 shs$64.56 million03/22/2024$1.38$1.39+0.72%$1.53$1.33197,496 shs$66.97 million03/21/2024$1.11$1.38+24.32%$1.39$1.11115,731 shs$66.49 million03/20/2024$1.23$1.11-9.76%$1.26$1.1087,636 shs$53.48 million03/19/2024$1.29$1.23-4.65%$1.31$1.2234,149 shs$59.26 million03/18/2024$1.29$1.29-0.01%$1.34$1.2847,195 shs$62.15 million03/15/2024$1.29$1.29$1.32$1.2921,358 shs$62.15 million03/14/2024$1.29$1.29$1.33$1.2910,402 shs$62.15 millionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/13/2024$1.30$1.29-0.77%$1.35$1.2923,742 shs$61.92 million03/12/2024$1.33$1.30-1.89%$1.32$1.2947,168 shs$62.40 million03/11/2024$1.34$1.33-1.12%$1.37$1.3128,488 shs$63.60 million03/08/2024$1.35$1.34-0.74%$1.36$1.3238,698 shs$64.32 million03/07/2024$1.36$1.35-0.74%$1.37$1.3335,356 shs$64.80 million03/06/2024$1.31$1.36+3.82%$1.40$1.3219,433 shs$65.28 million03/05/2024$1.29$1.31+1.55%$1.35$1.2671,707 shs$62.69 million03/04/2024$1.33$1.29-3.01%$1.37$1.22105,651 shs$61.73 million03/01/2024$1.39$1.33-4.32%$1.39$1.3177,546 shs$63.64 million02/29/2024$1.42$1.39-2.11%$1.46$1.3252,135 shs$66.51 million02/28/2024$1.52$1.42-6.58%$1.47$1.39197,245 shs$67.95 million02/27/2024$1.37$1.52+10.95%$1.54$1.37253,963 shs$72.73 million02/26/2024$1.40$1.37-2.14%$1.40$1.3633,931 shs$65.55 million02/23/2024$1.35$1.41+4.44%$1.41$1.30111,605 shs$67.43 million02/22/2024$1.39$1.35-2.88%$1.41$1.3559,098 shs$64.56 million02/21/2024$1.40$1.39-0.71%$1.42$1.3561,131 shs$66.47 million02/20/2024$1.38$1.40+1.45%$1.43$1.38146,602 shs$66.95 million02/19/2024$1.38$1.38$1.40$1.3193,900 shs$65.99 million02/16/2024$1.32$1.38+4.55%$1.40$1.3190,242 shs$65.77 million02/15/2024$1.28$1.32+3.13%$1.34$1.2839,093 shs$62.91 million02/14/2024$1.29$1.28-0.78%$1.35$1.2753,293 shs$61.01 million02/13/2024$1.33$1.29-3.01%$1.35$1.2073,998 shs$61.48 million02/12/2024$1.35$1.33-1.48%$1.36$1.3269,575 shs$63.39 million02/09/2024$1.31$1.35+3.05%$1.39$1.3138,327 shs$64.34 million02/08/2024$1.30$1.31+0.77%$1.34$1.1829,215 shs$62.44 million02/07/2024$1.38$1.30-5.80%$1.38$1.28125,613 shs$55.24 million Related Companies: AXTI Stock Chart ATOM Stock Chart MRAM Stock Chart PXLW Stock Chart GSIT Stock Chart KOPN Stock Chart MOBX Stock Chart CNDB Stock Chart FORA Stock Chart CAN Stock Chart Receive POET Stock News and Ratings via EmailSign-up to receive the latest news and ratings for POET Technologies and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:POET) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding POET Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.